Lerins supported Happydemics in its €13 million Series B financing round with Adelie and Wille Finance AG.
This round of funding will enable the specialist in measuring the impact of advertising campaigns (brand lift), to accelerate its growth and development, particularly in Europe, the United States and the Middle East.
Founded in 2015, the start-up led by Tarek Ouagguini already generates 75% of its annual recurring revenues outside France, and measures between 500 and 700 advertising campaigns every month. It enables advertisers to accurately assess the performance of their advertising campaigns and optimize their ROI.
The company unifies the measurement of all media, traditional and emerging, thanks to a unique methodology, consolidated by over 25,000 benchmarks.
The Lerins team involved in this transaction with Happydemics was made up of Laurent Julienne, partner, Marc Gervais, counsel and Anne Souchet, associate.
